However, the analgesic effects of liraglutide were not observed in GSK3 (S9A) mice, indicating that liraglutide relieved diabetic pain by suppressing the NLRP3 inflammasome in microglia through GSK3 [84]
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)
The most important "diet" on GLP-1 is not a named plan but rather the protein-first, whole-foods approach that consistently delivers results
*Monitored by Board-Certified Doctor 1
Your Options Request a formulary exception your doctor can argue medical necessity What to do if Wegovy is not covered Cardiovascular risk reduction if you have heart disease risk factors, Wegovy's FDA-approved indication (March 2024) strengthens your case Consider Zepbound as of October 1, 2026 it returns as an "additional preferred option" alongside Wegovy on most Aetna/CVS Caremark plans [10] Zepbound coverage on Aetna Switch plans during open enrollment if your employer offers multiple options, check for GLP-1 coverage Explore self-pay options NovoCare ($349/mo) and patient assistance may help Wegovy Cost Guide About Wegovy's FDA Approvals Important: Sleep Apnea Coverage Goes to Zepbound, Not Wegovy Note: Zepbound (tirzepatide), not Wegovy, was FDA-approved to treat obstructive sleep apnea (OSA) in adults with obesity on December 20, 2024
The work so far has been done in labs or with animals and is still in early stages
